These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19042039)

  • 1. Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects.
    Katusic ZS; d'Uscio LV; Nath KA
    Trends Pharmacol Sci; 2009 Jan; 30(1):48-54. PubMed ID: 19042039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrahydrobiopterin and cardiovascular disease.
    Moens AL; Kass DA
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2439-44. PubMed ID: 16946131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease.
    Cunnington C; Van Assche T; Shirodaria C; Kylintireas I; Lindsay AC; Lee JM; Antoniades C; Margaritis M; Lee R; Cerrato R; Crabtree MJ; Francis JM; Sayeed R; Ratnatunga C; Pillai R; Choudhury RP; Neubauer S; Channon KM
    Circulation; 2012 Mar; 125(11):1356-66. PubMed ID: 22315282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (6R)-5,6,7,8-tetrahydro-L-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm.
    Mayahi L; Heales S; Owen D; Casas JP; Harris J; MacAllister RJ; Hingorani AD
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1334-9. PubMed ID: 17413035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.
    Alp NJ; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):413-20. PubMed ID: 14656731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension.
    Khoo JP; Zhao L; Alp NJ; Bendall JK; Nicoli T; Rockett K; Wilkins MR; Channon KM
    Circulation; 2005 Apr; 111(16):2126-33. PubMed ID: 15824200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
    Channon KM
    Trends Cardiovasc Med; 2004 Nov; 14(8):323-7. PubMed ID: 15596110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects.
    Ihlemann N; Rask-Madsen C; Perner A; Dominguez H; Hermann T; Køber L; Torp-Pedersen C
    Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H875-82. PubMed ID: 12730050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of vascular tetrahydrobiopterin bioavailability.
    Starr A; Hussein D; Nandi M
    Vascul Pharmacol; 2013 Mar; 58(3):219-30. PubMed ID: 23634439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase.
    Kuzkaya N; Weissmann N; Harrison DG; Dikalov S
    J Biol Chem; 2003 Jun; 278(25):22546-54. PubMed ID: 12692136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydrobiopterin improves cardiac and pulmonary function after cardiopulmonary bypass.
    Szabó G; Seres L; Soós P; Gorenflo M; Merkely B; Horkay F; Karck M; Radovits T
    Eur J Cardiothorac Surg; 2011 Sep; 40(3):695-700. PubMed ID: 21324707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydrobiopterin (BH
    Francis BN; Salameh M; Khamisy-Farah R; Farah R
    Cardiovasc Ther; 2018 Feb; 36(1):. PubMed ID: 29151278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease.
    Moens AL; Kass DA
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):238-46. PubMed ID: 17878750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension.
    Zheng JS; Yang XQ; Lookingland KJ; Fink GD; Hesslinger C; Kapatos G; Kovesdi I; Chen AF
    Circulation; 2003 Sep; 108(10):1238-45. PubMed ID: 12925450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of tetrahydrobiopterin in inflammation and cardiovascular disease.
    McNeill E; Channon KM
    Thromb Haemost; 2012 Nov; 108(5):832-9. PubMed ID: 23052970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells.
    Cai S; Khoo J; Channon KM
    Cardiovasc Res; 2005 Mar; 65(4):823-31. PubMed ID: 15721862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease.
    Maier W; Cosentino F; Lütolf RB; Fleisch M; Seiler C; Hess OM; Meier B; Lüscher TF
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):173-8. PubMed ID: 10672847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CR6-interacting factor 1 deficiency reduces endothelial nitric oxide synthase activity by inhibiting biosynthesis of tetrahydrobiopterin.
    Lee I; Kim S; Nagar H; Choi SJ; Jeon BH; Piao S; Kim CS
    Sci Rep; 2020 Jan; 10(1):842. PubMed ID: 31964986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydrobiopterin lowers muscle sympathetic nerve activity and improves augmentation index in patients with chronic kidney disease.
    Park J; Liao P; Sher S; Lyles RH; Deveaux DD; Quyyumi AA
    Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(3):R208-18. PubMed ID: 25477424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals.
    Higashi Y; Sasaki S; Nakagawa K; Fukuda Y; Matsuura H; Oshima T; Chayama K
    Am J Hypertens; 2002 Apr; 15(4 Pt 1):326-32. PubMed ID: 11991218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.